Log in
Enquire now

List of ProBioGen AG patents

List of ProBioGen AG patents
List of Mahindra Automotive patents
List of Askoll patents
List of Cartasite patents
List of founders from Texas
List of companies in David Spector's investment portfolio
Patents where
Current Assignee
Name
is
‌
ProBioGen AG
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 7531351 Liquid-gas-phase exposure reactor for cell culturing

Patent 7531351 was granted and assigned to ProBioGen AG on May, 2009 by the United States Patent and Trademark Office.

‌
ProBioGen AG
United States Patent and Trademark Office
United States Patent and Trademark Office
7531351
May 12, 2009
‌
US Patent 8940534 Immortalized avian cell lines for virus production

Patent 8940534 was granted and assigned to ProBioGen AG on January, 2015 by the United States Patent and Trademark Office.

‌
ProBioGen AG
United States Patent and Trademark Office
United States Patent and Trademark Office
8940534
January 27, 2015
‌
US Patent 8642292 Process for producing molecules containing specialized glycan structures

Patent 8642292 was granted and assigned to ProBioGen AG on February, 2014 by the United States Patent and Trademark Office.

‌
ProBioGen AG
United States Patent and Trademark Office
United States Patent and Trademark Office
8642292
February 4, 2014
‌
US Patent 7501232 Method for cell selection

Patent 7501232 was granted and assigned to ProBioGen AG on March, 2009 by the United States Patent and Trademark Office.

‌
ProBioGen AG
United States Patent and Trademark Office
United States Patent and Trademark Office
7501232
March 10, 2009
‌
US Patent 8911995 Culture system and method for immunogenicity and immunofunction testing in vitro

Patent 8911995 was granted and assigned to ProBioGen AG on December, 2014 by the United States Patent and Trademark Office.

‌
ProBioGen AG
United States Patent and Trademark Office
United States Patent and Trademark Office
8911995
December 16, 2014
‌
US Patent 9732325 MVA virus and uses thereof

Patent 9732325 was granted and assigned to ProBioGen AG on August, 2017 by the United States Patent and Trademark Office.

‌
ProBioGen AG
‌
ProBioGen AG
United States Patent and Trademark Office
United States Patent and Trademark Office
9732325
August 15, 2017
‌
US Patent 8815540 Productivity augmenting protein factor, novel cell lines and uses thereof

Patent 8815540 was granted and assigned to ProBioGen AG on August, 2014 by the United States Patent and Trademark Office.

‌
ProBioGen AG
United States Patent and Trademark Office
United States Patent and Trademark Office
8815540
August 26, 2014
‌
US Patent 9163089 Enhancement of protein production yield mediated by a fast shuttling CDC42 GTPase

Patent 9163089 was granted and assigned to ProBioGen AG on October, 2015 by the United States Patent and Trademark Office.

‌
ProBioGen AG
United States Patent and Trademark Office
United States Patent and Trademark Office
9163089
October 20, 2015
‌
US Patent 8679839 Cell line from rousettus as host cell for pathogen amplification

Patent 8679839 was granted and assigned to ProBioGen AG on March, 2014 by the United States Patent and Trademark Office.

‌
ProBioGen AG
United States Patent and Trademark Office
United States Patent and Trademark Office
8679839
March 25, 2014
‌
US Patent 9273289 Depletion of host cell components from live vector vaccines

Patent 9273289 was granted and assigned to ProBioGen AG on March, 2016 by the United States Patent and Trademark Office.

‌
ProBioGen AG
United States Patent and Trademark Office
United States Patent and Trademark Office
9273289
March 1, 2016
‌
US Patent 9765158 Methods for preparation of fucose-linked site specific conjugates of proteins with toxins, adjuvants, detection labels and pharmacokinetic half life extenders

Patent 9765158 was granted and assigned to ProBioGen AG on September, 2017 by the United States Patent and Trademark Office.

‌
ProBioGen AG
United States Patent and Trademark Office
United States Patent and Trademark Office
9765158
September 19, 2017
‌
US Patent 11999975 Method for purifying an enveloped virus

Patent 11999975 was granted and assigned to ProBioGen AG on June, 2024 by the United States Patent and Trademark Office.

‌
ProBioGen AG
‌
ProBioGen AG
United States Patent and Trademark Office
United States Patent and Trademark Office
11999975
June 4, 2024
12 results
0 selected
12 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us